Marc‐Olivier Timsit

Author

Marc‐Olivier Timsit

Université Paris Cité

Also Known As

M TIMSIT, M. Timsit, Marc-Olivier TIMSIT, Marc-Olivier Timsit, Marc‐Olivier Timsit, Timsit, Marc-Olivier

102

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Université Paris Cité Délégation Paris 5 Hôpital Européen Georges-Pompidou Hôpital Necker-Enfants Malades Assistance Publique – Hôpitaux de Paris

About

Marc‐Olivier Timsit is an author at Université Paris Cité specializing in urology, medicine, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	311
2	Health Sciences	3	3	1.1K
3	Engineering	2	2	76
4	Education	1	1	61
5	Biomedical Engineering	1	1	12

Marc‐Olivier Timsit

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study Olivier Rouvière, Philippe Puech, Raphaële Renard‐Penna, The Lancet Oncology UrologyMultiparametric MriMedical ImagingBiopsy-naive PatientsBenign Prostatic Hyperplasia	2018	1K
Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study Alexandre Loupy, Caroline Suberbielle‐Boissel, Julien Zuber, Transplantation	2010	155
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study Patrick R. Benusiglio, Sophie Giraud, Sophie Deveaux, Orphanet Journal of Rare Diseases	2014	103
Prospective study of safety margins in partial nephrectomy: Intraoperative assessment and contribution of frozen section analysis Marc‐Olivier Timsit, Jean-Philippe Bazin, Nicolas Thiounn, Urology Intraoperative ConsultationUrologySurgical OncologyPatient SafetyPerioperative Safety	2006	99
Molecular Analyte Profiling of the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder Cancer Aurélie Bisiaux, Nicolas Thiounn, Marc‐Olivier Timsit, The Journal of Urology	2009	87
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA Lucile Amrouche, Olivier Aubert, Caroline Suberbielle, Transplantation	2017	80
Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour Christine Hoeffel, M. Pousset, Marc‐Olivier Timsit, European Radiology Medical UltrasoundUrologyEngineeringMedical ImagingRadiofrequency Ablation	2010	64
Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): Update on Carmena trial with focus on intermediate IMDC-risk population. Arnaud Méjean, Simon Thézenas, Christine Chevreau, Journal of Clinical Oncology Surgical OncologyClinical EndpointPrognosisClinical SpecialtiesMultimodality	2019	61
Hybrid tumour ‘oncocytoma‐chromophobe renal cell carcinoma’ of the kidney: a report of seven sporadic cases Nicolas Barry Delongchamps, Louise Galmiche, D. Eiss, British Journal of Urology	2009	57
Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? Marc Gigante, Y. Neuzillet, Jean‐Jacques Patard, British Journal of Urology	2012	55

Page 1